Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by
deficient activity of the enzyme alpha-galactosidase. While AFD is recognized as a …

Fabry Disease (FD) is one of the most prevalent lysosomal storage disorders, resulting from
mutations in the GLA gene located on the X chromosome. This genetic mutation triggers glo …

Fabry disease is caused by a deficiency of lysosomal alpha galactosidase and has a very
large genotypic and phenotypic spectrum. Some patients who carry hypomorphic mutations …

Fabry disease (FD) is an X-linked metabolic disease caused by a deficiency in α-
galactosidase A (α-Gal A) activity. This causes accumulation of glycosphingolipids …

Fabry disease is a lysosomal storage disease caused by mutations in the GLA gene that
encodes alpha-galactosidase (AGAL). The disease causes abnormal globotriaosylceramide …

Enzyme replacement therapy is the only therapeutic option for Fabry patients with
completely absent AGAL activity. However, the treatment has side effects, is costly, and …

Objective To detect the serum procalcitonin (PCT) level and determine its relationship with
the infarct volume in young patients with acute cerebral infarction. Methods According to the …

Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of
alpha-galactosidase causing lysosomal overload of sphingolipids. FD cardiomyopathy is …

Fabry disease is an X-linked inheritable lysosomal storage disease caused by various
mutations of the galactosidase α gene resulting in α-galactosidase deficiency. Chronic …

Introduction Lipidomics analysis or lipid profiling is a system-based analysis of all lipids in a
sample to provide a comprehensive understanding of lipids within a biological system. In the …